Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphataemia Receiving Hemodialysis
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Bixalomer (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 10 Jun 2017 Biomarkers information updated
- 26 Jan 2017 Status changed from active, no longer recruiting to completed.
- 24 Mar 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.